Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TG103 Injection in Overweight/Obese Non-diabetic Adults
CTR20240075Phase 2Completed
- Sponsor
- CSPC Baike Biopharmaceutical
- Start
- Jan 2024
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of GX-G6 in obesity, Overweight, sponsored by CSPC Baike Biopharmaceutical. Started Jan 2024; status: completed.
02
Drugs
GX-G6
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on CTR20240075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240075.